Welcome to

SELPHYL® SCIENCE

Home of the Next Generation PRP

THE SELPHYL® PROCESS

Step 6

The patient’s own PRFM is ready for use as deemed appropriate by the clinical use requirements.

Step 5

Fibrin polymerization begins and the PRP remains liquid for approximately 20 minutes before forming PRFM.

Step 4

The platelets and plasma are then transferred in a closed system to a second vacuum tube containing a small amount of calcium chloride solution.

Step 1

During a short office visit (20 minutes), a small amount of a patient’s own blood is drawn into a vacuum collection tube containing a cell separator gel.

Step 2

The tube is then placed into a centrifuge and spun for six minutes to separate the blood into a supernatant plasma/platelet suspension.

Step 3

The red and white blood cells are located below the cell separator gel.

THE SELPHYL® KIT

AFFORDABLE AND COST-EFFECTIVE

4cc or 8cc of PRFM available for administration

SAFETY BLOOD COLLECTION SET: “Butterfly Wing”

Tourniquet

PROPRIETARY VACUTAINER® PRP TUBE: “Yellow Top”

4cc or 8cc of PRFM available for administration

DEVICE FOR THE STERILE TRANSFER OF FLUID

Safe, closed system
Needle protection sleeves (Jacketed)

PRFM PREPARATION TUBE — “Red Top”

4cc liquid per tube
Hemogard™ Cap
Calcium Chloride Solution

ADDITIONAL MATERIALS INCLUDED

Alcohol wipes and tracking labels

Regulatory Status: FDA cleared 510(k) Class II medical device

Selphyl Power of Blood Platelets Plasma PRFM PRP

THE POWER OF BLOOD

As part of the body’s capacity to heal itself, platelets and other components in human blood migrate to a site of injury. Platelets are known to release a variety of factors that respond to tissue injury, where they initiate and promote healing. By concentrating platelets at the site of injury, physicians have the potential to enhance the body’s natural capacity for healing.

The SELPHYL® System provides the exact amount of Calcium Chloride to PRP producing Platelet-rich Fibrin Matrix. Other systems produce PRP, not PRFM. Fibrin matrix creates a scaffold to localize platelets to the site of injection and allows for sustained growth factor release, migration of stem cells and reservoir for regenerative signaling.

1 Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004; 91(1):4-15
2 Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma. Am J Sports Med. 2009; 37:2259-2272.

PLATELETS RELEASE GROWTH FACTORS

As soon as SELPHYL® - prepared PRFM is administered, growth factors are released through the formation of a three-dimensional cross-linked fibrin matrix which is essential to the platelet plug as it serves as a binding site for both platelets and growth factors allowing their sustained release.

This scaffolding (fibrin matrix) localizes the growth factors increasing their concentration at the desired location and guiding tissue regeneration. Studies have shown that platelet growth factors are released for up to seven days, supporting collagen production and increased vascularization, which results in overall skin improvements.

Sustained Growth Factor Release

Selphyl Platelets Release Growth Factors PRFM PRP

ULTRAPURE PRFM “LIQUID GOLD”

SELPHYL® is based on the principle that human blood and platelets possess all the essential elements needed for tissue. It is designed to produce PRFM devoid of contaminating red and white blood cells. Other Systems are designed to collect white blood cells for diagnostic testing. The proprietary gel separator design is one of the key advantages of the SELPHYL® System.